ZA200502374B - Use of posaconazole for the treatment of fungal infections - Google Patents

Use of posaconazole for the treatment of fungal infections Download PDF

Info

Publication number
ZA200502374B
ZA200502374B ZA200502374A ZA200502374A ZA200502374B ZA 200502374 B ZA200502374 B ZA 200502374B ZA 200502374 A ZA200502374 A ZA 200502374A ZA 200502374 A ZA200502374 A ZA 200502374A ZA 200502374 B ZA200502374 B ZA 200502374B
Authority
ZA
South Africa
Prior art keywords
posaconazole
treatment
prevention
substance
composition
Prior art date
Application number
ZA200502374A
Other languages
English (en)
Inventor
Courtney Rachel
Mark A Laughlin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA200502374B publication Critical patent/ZA200502374B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200502374A 2002-09-23 2005-03-22 Use of posaconazole for the treatment of fungal infections ZA200502374B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41298502P 2002-09-23 2002-09-23

Publications (1)

Publication Number Publication Date
ZA200502374B true ZA200502374B (en) 2006-12-27

Family

ID=32030948

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200502374A ZA200502374B (en) 2002-09-23 2005-03-22 Use of posaconazole for the treatment of fungal infections

Country Status (11)

Country Link
US (1) US20040058974A1 (es)
EP (1) EP1542681A2 (es)
JP (1) JP2006503839A (es)
CN (1) CN1688306A (es)
AU (1) AU2003282806A1 (es)
BR (1) BR0314763A (es)
CA (1) CA2499897A1 (es)
MX (1) MXPA05003124A (es)
NO (1) NO20051987L (es)
WO (1) WO2004026303A2 (es)
ZA (1) ZA200502374B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7406092B2 (en) * 2003-07-21 2008-07-29 Qlogic, Corporation Programmable pseudo virtual lanes for fibre channel systems
GB0409077D0 (en) * 2004-04-23 2004-05-26 Neutec Pharma Plc Treatment of fungal infections
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
EP1776109B1 (en) 2004-08-13 2008-12-31 Schering-Plough Ltd. Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
MX2008015275A (es) * 2006-05-30 2009-02-06 Elan Pharma Int Ltd Formulaciones de posaconazol en nanoparticulas.
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
WO2013013223A1 (en) 2011-07-20 2013-01-24 Brigham Young University Hydrogel materials incorporating eluting ceragenin compound
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
WO2013109236A2 (en) 2011-12-21 2013-07-25 Colgate-Palmolive Company Oral care compositions
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
US10039285B2 (en) 2012-05-02 2018-08-07 Brigham Young University Ceragenin particulate materials and methods for making same
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
BR112015008804A2 (pt) 2012-10-17 2017-07-04 Univ Brigham Young tratamento e prevenção de mastite
CA2897150C (en) 2013-01-07 2021-07-13 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
AU2014234992B2 (en) 2013-03-15 2018-01-18 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity

Also Published As

Publication number Publication date
JP2006503839A (ja) 2006-02-02
CA2499897A1 (en) 2004-04-01
WO2004026303A2 (en) 2004-04-01
CN1688306A (zh) 2005-10-26
WO2004026303A3 (en) 2004-04-29
EP1542681A2 (en) 2005-06-22
NO20051987L (no) 2005-04-22
US20040058974A1 (en) 2004-03-25
MXPA05003124A (es) 2005-06-22
AU2003282806A1 (en) 2004-04-08
BR0314763A (pt) 2005-07-26

Similar Documents

Publication Publication Date Title
ZA200502374B (en) Use of posaconazole for the treatment of fungal infections
KR101834024B1 (ko) 치환된 베타―시클로덱스트린에 의해 안정화된 포사코나졸 정맥내 용액 제제
HUE027184T2 (en) Combination of azelastine and cyclesonide
JP2009527465A (ja) 筋骨格障害およびそれに関連する症状の処置のための方法、組成物およびキット
EP2846780B1 (en) Solubilized capsule formulation of 1,1-dimethylethyl [(1s)-1-{[(2s,4r)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({(1r,2s)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate
JP2020535227A5 (es)
CN106999461A (zh) 选择性s1p1受体激动剂的给药方案
Cowart et al. A phase 1 randomized study of single intravenous infusions of the novel nitroxyl donor BMS‐986231 in healthy volunteers
Hay et al. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole
CN116685353A (zh) 血管性水肿的预防和治疗
IL299568A (en) A combination of zibutantan and dapagliflozin for the treatment of chronic kidney disease
CN102805731A (zh) 泊沙康唑干混悬剂及其制备方法
McManus et al. Antifungal drugs
JP2915296B2 (ja) 抗真菌製剤
FRANCO et al. Saperconazole in the treatment of systemic and subcutaneous mycoses
Kullberg et al. Therapy of invasive fungal infections
CN101879169B (zh) 一种治疗血管相关疾病的复方制剂及其制备方法
US20060141028A1 (en) Cyclosporin formulations
CN117545477A (zh) Mmp-12抑制剂的安全施用
Isles et al. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension
AU2016259775A1 (en) Cabazitaxel and its use for treating cancer
Tablets et al. PrAPO-SAXAGLIPTIN
CA3206840A1 (en) Methods of treatment
JPWO2014188729A1 (ja) 経口用組成物
CA2812968A1 (en) Pharmaceutical formulation containing phenytoin sodium and magnesium stearate